Literature DB >> 33047276

Synthesis of 4-alkylaminoimidazo[1,2-a]pyridines linked to carbamate moiety as potent α-glucosidase inhibitors.

Mina Saeedi1,2, Maryam Raeisi-Nafchi3, Sepideh Sobhani3, Seyedeh Sara Mirfazli4, Mahsa Zardkanlou5, Somayeh Mojtabavi5, Mohammad Ali Faramarzi5, Tahmineh Akbarzadeh6,7.   

Abstract

In this work, various imidazo[1,2-a]pyridines linked to carbamate moiety were designed, synthesized, and evaluated for their α-glucosidase inhibitory activity. Among synthesized compounds, 4-(3-(tert-Butylamino)imidazo[1,2-a]pyridin-2-yl)phenyl p-tolylcarbamate (6d) was the most potent compound (IC50 = 75.6 µM) compared with acarbose as the reference drug (IC50 = 750.0 µM). Kinetic study of compound 6d indicated a competitive inhibition. Also, the molecular docking study suggested desired interactions with the active site residues. In particular, hydrogen bonds and electrostatic interactions constructed by compound 6d afforded well-oriented conformation in the 3A4A active site.
© 2020. Springer Nature Switzerland AG.

Entities:  

Keywords:  4-Alkylaminoimidazo[1,2-a]pyridine; Carbamates; Synthesis; α-Glucosidase

Mesh:

Substances:

Year:  2020        PMID: 33047276     DOI: 10.1007/s11030-020-10137-8

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  23 in total

1.  Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis.

Authors:  Floris A van de Laar; Peter L Lucassen; Reinier P Akkermans; Eloy H van de Lisdonk; Guy E Rutten; Chris van Weel
Journal:  Diabetes Care       Date:  2005-01       Impact factor: 19.112

2.  Current prevalence of Type 1 and Type 2 diabetes in adults and children in the UK.

Authors:  N Holman; B Young; R Gadsby
Journal:  Diabet Med       Date:  2015-09       Impact factor: 4.359

Review 3.  Carbohydrate-based mimetics in drug design: sugar amino acids and carbohydrate scaffolds.

Authors:  Sibylle A W Gruner; Elsa Locardi; Elisabeth Lohof; Horst Kessler
Journal:  Chem Rev       Date:  2002-02       Impact factor: 60.622

4.  Design, synthesis, in vitro, and in silico studies of novel diarylimidazole-1,2,3-triazole hybrids as potent α-glucosidase inhibitors.

Authors:  Mina Saeedi; Maryam Mohammadi-Khanaposhtani; Mohammad Sadegh Asgari; Nafiseh Eghbalnejad; Somaye Imanparast; Mohammad Ali Faramarzi; Bagher Larijani; Mohammad Mahdavi; Tahmineh Akbarzadeh
Journal:  Bioorg Med Chem       Date:  2019-10-15       Impact factor: 3.641

5.  Synthesis and biological evaluation of coumarin derivatives as α-glucosidase inhibitors.

Authors:  Xue-Tao Xu; Xu-Yang Deng; Jie Chen; Qi-Ming Liang; Kun Zhang; Dong-Li Li; Pan-Pan Wu; Xi Zheng; Ren-Ping Zhou; Zheng-Yun Jiang; Ai-Jun Ma; Wen-Hua Chen; Shao-Hua Wang
Journal:  Eur J Med Chem       Date:  2019-12-30       Impact factor: 6.514

Review 6.  Recent Advances in Synthetic α-Glucosidase Inhibitors.

Authors:  Zhiyang Liu; Shutao Ma
Journal:  ChemMedChem       Date:  2017-06-01       Impact factor: 3.466

7.  Synthesis of new indazole based dual inhibitors of α-glucosidase and α-amylase enzymes, their in vitro, in silico and kinetics studies.

Authors:  Rafaila Rafique; Khalid Mohammed Khan; Sridevi Chigurupati; Abdul Wadood; Ashfaq Ur Rehman; Arunkumar Karunanidhi; Shehryar Hameed; Muhammad Taha; Mariya Al-Rashida
Journal:  Bioorg Chem       Date:  2019-08-23       Impact factor: 5.275

8.  A new class of glucosidase inhibitor: analogues of the naturally occurring glucosidase inhibitor salacinol with different ring heteroatom substituents and acyclic chain extension.

Authors:  Hui Liu; Lyann Sim; David R Rose; B Mario Pinto
Journal:  J Org Chem       Date:  2006-04-14       Impact factor: 4.354

9.  Dihydropyridines as potential α-amylase and α-glucosidase inhibitors: Synthesis, in vitro and in silico studies.

Authors:  Hina Yousuf; Shahbaz Shamim; Khalid Mohammed Khan; Sridevi Chigurupati; Shehryar Hameed; Muhammad Naseem Khan; Muhammad Taha; Minhajul Arfeen
Journal:  Bioorg Chem       Date:  2020-01-15       Impact factor: 5.275

Review 10.  Alpha-glucosidase inhibitors in the early treatment of type 2 diabetes.

Authors:  Floris Alexander van de Laar
Journal:  Vasc Health Risk Manag       Date:  2008
View more
  5 in total

1.  BF3-etherate promoted facile access to vinyloxyimidazopyridines: a metal-free sustainable approach.

Authors:  Saurabh Kumar Tiwari; Mohd Nazeef; Ankit Verma; Ankit Kumar; Vikas Yadav; Neetu Yadav; Saif Ansari; I R Siddiqui
Journal:  Mol Divers       Date:  2021-05-16       Impact factor: 2.943

2.  Crystal structure and Hirshfeld surface analysis of 2-oxo-2-phenyl-ethyl 3-nitroso-2-phenyl-imidazo[1,2-a]pyridine-8-carboxyl-ate.

Authors:  Fouad El Kalai; Cemile Baydere; Necmi Dege; Abdulmalik Abudunia; Noureddine Benchat; Khalid Karrouchi
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2022-02-15

Review 3.  A review on α-glucosidase inhibitory activity of first row transition metal complexes: a futuristic strategy for treatment of type 2 diabetes.

Authors:  Marzieh Sohrabi; Mohammad Reza Binaeizadeh; Aida Iraji; Bagher Larijani; Mina Saeedi; Mohammad Mahdavi
Journal:  RSC Adv       Date:  2022-04-20       Impact factor: 4.036

4.  Design, synthesis, and molecular docking studies of diphenylquinoxaline-6-carbohydrazide hybrids as potent α-glucosidase inhibitors.

Authors:  Keyvan Pedrood; Zahra Rezaei; Kimia Khavaninzadeh; Bagher Larijani; Aida Iraji; Samanesadat Hosseini; Somayeh Mojtabavi; Mehdi Dianatpour; Hossein Rastegar; Mohammad Ali Faramarzi; Haleh Hamedifar; Mir Hamed Hajimiri; Mohammad Mahdavi
Journal:  BMC Chem       Date:  2022-07-31

Review 5.  A Review on Antidiabetic Activity of Centaurea spp.: A New Approach for Developing Herbal Remedies.

Authors:  Samaneh Fattaheian-Dehkordi; Reza Hojjatifard; Mina Saeedi; Mahnaz Khanavi
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-05       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.